A Agilent Technologies

8-K Current Report

Filed: February 25, 2026

Health Care

Laboratory Analytical Instruments

Agilent Technologies (A) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q results disclosed via press release in Exhibit 99.1 — actual revenue, EPS, and guidance figures found there
• Non-GAAP metrics exclude restructuring and amortization charges, which management treats as non-recurring for performance measurement

+1 more insights

Other Agilent Technologies 8-K Filings

8-K Mar 6, 2026

Get deeper insights on Agilent Technologies

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.